Pharmacologyproject Nasalis (Resebidrag Eureka ,Island)
|Coordinator||PARTNERS FÖR UTVECKLINGSINVESTERINGAR INOM LIFE - Partners för Utvecklingsinvesteringar inom Life Sciences, P.U.L.S. AB|
|Funding from Vinnova||SEK 15 000|
|Project duration||August 2015 - October 2015|
|Venture||Resebidrag EUREKA och Eurostars|
Purpose and goal
The projects aim to establish i collaboration between P.U.L.S. AB and University of Iceland to create a projectstructure for a new innovation platform. Many years of research has resulted in in a novel drug adminstration technology. P.U.L.S. AB has sucessfully during the past 13 years brought ideas into stable SMEs which have been exited into larger pharma companies for market introduction. The meeting generated a good dialogue between the corresponding parties, whom are now evaluating potential collaboration projects.
Results and expected effects
All set goals were met within the Vinnova Resebidrag-grant framework. A strategic plan is developed describing the future collaboration of University of Iceland , Haranja and PULS. A process analyazing potential collaboration projects is initiated, and a plan for platform verification is developed in correspondance to potential projects.
Approach and implementation
PULS has met with Haranja and University of Iceland during 2 days to evaluate project structure, plan of action and a potential Eureka application. The meeting has generated a preliminary draft of patway to market for the discussed potential projects.